NLRP3 and head and neck squamous cell carcinoma: Studies have demonstrated that NLRP3 is overexpressed in human tissues and that NLRP3 initiates the release of inflammatory cytokines such as IL-1β and IL-18, which are also associated with HNSCC tumorigenesis.